We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Illustration

Next Generation SARS-CoV-2 Test Measures Response to COVID-19 Vaccine and Neutralizing Antibody Levels in 10 Minutes

The second generation version of a rapid neutralizing antibody test for COVID-19 will not only show if the users have responded to their COVID-19 vaccine but also perform a semi-quantitative analysis of their neutralizing antibody levels in a single test. More...
13 Oct 2021
Illustration

Study Examines Proteins in Saliva to Predict COVID-19 Severity Risk in Children with Help of AI Model

A team of researchers is conducting a study to look at the relationship between proteins called cytokines in saliva and COVID-19 infection to help predict the severity of infection with the help of an artificial intelligence (AI) model. More...
13 Oct 2021
Illustration

CT Values Should Not Be Used to Assess Performance of SARS-CoV-2 PCR Tests or Triage COVID-19 Patients, Finds Study

A novel study has shown that coronavirus test cycle threshold (Ct) values should not be used to assess the performance of coronavirus tests or to triage COVID-19 patients. More...
13 Oct 2021
Illustration

Merck and Ridgeback Request FDA Emergency Use Authorization for First-Ever COVID-19 Antiviral Pill

Merck (Kenilworth, NJ, USA) and Ridgeback Biotherapeutics (Miami, FL, USA) have submitted an Emergency Use Authorization (EUA) application to the US Food and Drug Administration (FDA) for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. More...
12 Oct 2021
Image: The Eucovent (Photo courtesy of University of South Florida)

Innovative Device That Allows Two COVID-19 Patients to Be Ventilated by Single Machine to Help End Worldwide Ventilator Shortage

A prototype device that allows two patients to be ventilated by a single machine could help solve the critical shortage of lifesaving ventilators seen around the world throughout the COVID-19 pandemic. More...
11 Oct 2021
Illustration

Samsung Biologics and Enzolytics to Jointly Develop and Manufacture Anti-SARS-CoV-2 Monoclonal Antibody Therapies

Samsung Biologics (Incheon, Korea), a contract development and manufacturing organization, and Enzolytics Inc. (Plano, TX, USA), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, have entered into a strategic CDMO partnership agreement for the development and manufacturing of anti-HIV and anti-SARS-CoV-2 monoclonal antibody therapies. More...
11 Oct 2021
Illustration

Prescribed Blood Thinners for COVID-19 Patients Lower Hospitalizations and Reduce Mortality by Almost Half

A study has found that having a protocol to use blood thinners for COVID-19 patients reduces patient mortality by almost half. More...
07 Oct 2021
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Cart
UMGSA-33369-VIL
Copyright © 2000-2024 Globetech Media. All rights reserved.